IONS
IONIS PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$43.52
−1.96%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 108.76x
- P/S forward
- 6.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.45x
- Price / sales
- 8.28x
- Price / cash flow
- -14.57x
Enterprise value
- Enterprise value
- $7.6B
- EV / sales
- 8.69x
- EV / EBITDA
- -15.83x
- EV / EBIT
- -12.77x
- Market cap
- $7.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026